(Q40198964)

18 September 2017

title

Immunologic evaluation of 10 different adjuvants for use in vaccines for chickens against highly pathogenic avian influenza virus (English)

1 reference

18 September 2017

1 reference

2

Erica Spackman

1 reference

18 September 2017

Nazir Ahmed Lone

1

1 reference

18 September 2017

Darrell Kapczynski

series ordinal

3

1 reference

18 September 2017

language of work or name

English

0 references

publication date

13 May 2017

1 reference

18 September 2017

1 reference

18 September 2017

volume

35

1 reference

18 September 2017

issue

26

1 reference

18 September 2017

page(s)

3401-3408

1 reference

Assessment of national strategies for control of high-pathogenicity avian influenza and low-pathogenicity notifiable avian influenza in poultry, with emphasis on vaccines and vaccination.

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Comparative assessment of humoral immune responses of aluminum hydroxide and oil-emulsion adjuvants in Influenza (H9N2) and Newcastle inactive vaccines to chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Evaluation of several adjuvants in avian influenza vaccine to chickens and ducks

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Influenza virus inactivation for studies of antigenicity and phenotypic neuraminidase inhibitor resistance profiling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Treatment of influenza virus with beta-propiolactone alters viral membrane fusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Reduced egg production in hens associated with avian influenza vaccines and formalin levels.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Intersegmental recombination between the haemagglutinin and matrix genes was responsible for the emergence of a highly pathogenic H7N3 avian influenza virus in British Columbia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Potency, efficacy, and antigenic mapping of H7 avian influenza virus vaccines against the 2012 H7N3 highly pathogenic avian influenza virus from Mexico

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Avian influenza virus isolation, propagation, and titration in embryonated chicken eggs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Hemagglutination assay for influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Alginate nanoparticles as a promising adjuvant and vaccine delivery system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Adjuvant effects of chitosan and calcium phosphate particles in an inactivated Newcastle disease vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Hemagglutination-inhibition assay for influenza virus subtype identification and the detection and quantitation of serum antibodies to influenza virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Removal of real-time reverse transcription polymerase chain reaction (RT-PCR) inhibitors associated with cloacal swab samples and tissues for improved diagnosis of Avian influenza virus by RT-PCR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Development of a real-time reverse transcriptase PCR assay for type A influenza virus and the avian H5 and H7 hemagglutinin subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

H5N2 Highly Pathogenic Avian Influenza Viruses from the US 2014-2015 outbreak have an unusually long pre-clinical period in turkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Evaluation of Montanide™ ISA 71 VG adjuvant during profilin vaccination against experimental coccidiosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Montanide™ ISA 71 VG adjuvant enhances antibody and cell-mediated immune responses to profilin subunit antigen vaccination and promotes protection against Eimeria acervulina and Eimeria tenella

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Vaccination with Clostridium perfringens recombinant proteins in combination with Montanide™ ISA 71 VG adjuvant increases protection against experimental necrotic enteritis in commercial broiler chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Evaluation of immunogenicity and protective efficacy of adjuvanted Salmonella Typhimurium ghost vaccine against salmonellosis in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Cross-protection against influenza virus infection by intranasal administration of M1-based vaccine with chitosan as an adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Adjuvant effects of mannose-binding lectin ligands on the immune response to infectious bronchitis vaccine in chickens with high or low serum mannose-binding lectin concentrations.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

The positive adjuvant effect of chitosan on antigen-specific cell-mediated immunity after chickens vaccination with live Newcastle disease vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Effective nasal influenza vaccine delivery using chitosan

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Cross-protection against influenza virus infection by intranasal administration of M2-based vaccine with chitosan as an adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Low molecular weight chitosan nanoparticles as new carriers for nasal vaccine delivery in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

An oral DNA vaccine against infectious haematopoietic necrosis virus (IHNV) encapsulated in alginate microspheres induces dose-dependent immune responses and significant protection in rainbow trout (Oncorrhynchus mykiss).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Immunological evaluation of an alginate-based conjugate as a vaccine candidate against Pseudomonas aeruginosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Development and characterization of a new carrier for vaccine delivery based on calcium-alginate nanoparticles: Safe immunoprotective approach against scorpion envenoming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Efficacies of vaccines containing alginate adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Chitosan and Sodium Alginate Combinations Are Alternative, Efficient, and Safe Natural Adjuvant Systems for Hepatitis B Vaccine in Mouse Model.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Comparison of adjuvant activities of aluminium phosphate, calcium phosphate and stearyl tyrosine for tetanus toxoid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Structure and adsorption properties of commercial calcium phosphate adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Comparison of the adjuvant activity of aluminum hydroxide and calcium phosphate on the antibody response towards Bothrops asper snake venom

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Calcium phosphate nanoparticles for transcutaneous vaccine delivery.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Calcium phosphate coupled Newcastle disease vaccine elicits humoral and cell mediated immune responses in chickens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

Antibody titer has positive predictive value for vaccine protection against challenge with natural antigenic-drift variants of H5N1 high-pathogenicity avian influenza viruses from Indonesia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

SEPPIC vaccine adjuvants for poultry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2017.05.010

10.1016/J.VACCINE.2017.05.010

7 January 2021

Identifiers

DOI

1 reference

18 September 2017

1 reference